All You Need to Know on the Ecuador Sessions 2020

After 3 years, SOLACI returns to Ecuador -this time to the beautiful city of Manta- to continue promoting the development of interventional cardiology in Latin America. Do not hesitate to participate in this important event that will undoubtedly be enriching for medical practice and, also, to improve the quality of life of patients in our region.

Jornadas Ecuador 2020

Below you will find all the relevant information you need to know about the Ecuador Regional Sessions 2020.

When?

March 6th & 7th, 2020.

Where?

They will take place in Manta, Ecuador. (Oro Verde Hotel).

How can I register?

By entering HERE.

Which are the registrations fees?

  • Specialists | USD 160.
  • Generales Physicians | USD 130.
  • Students | USD 100.
  • Technicians & Nurses | USD 80.

Scientific Program

Access the scientific program

Which are the relevant topics?

  • Acute Coronary Syndrome
  • Coronary interventionism.
  • Aortic Valve Interventions.
  • Mitral valve.
  • Antithrombotic Therapy
  • Atrial Fibrillation Intervention.
  • Pediatric intervention.
  • Live cases.
  • Clinical Case Contest for Young Interventionists
  • Imagen Contest.

Who are organizing these sessions?

The Latin American Society of Interventional Cardiology alongside with the Ecuadorian Society of Cardiovascular Interventions (SEICAV).

Contact

¿En qué consiste el Concurso de Imágenes?

It is an interactive activity consisting in the presentation of a case series based on imaging. One or more multiple-choice questions will be asked regarding these cases. Participants will send their answers through their smartphones, which will connect to the evaluation information system. The Contest will also include a few questions on general knowledge for entertainment purposes. The participant with more correct answers will be the winner. Its first price will be the fee for full registration, lodging and transportation costs to Chile Sessions 2016 (November 30th and December 1st).

What are the winners of the Imaging and Clinical Case Contests awarded?

All costs to some of the next SOLACI Sessions will be waived.

SOLACI Board

Jornadas SOLACI Director
Dr. Mario Araya (Chile).

Jornadas SOLACI Vice Director
Dr. Gustavo Vignolo (Uruguay).

SOLACI Sessions Scientific Committee Director
Dr. Marcio Montenegro (Brasil).

SEICAV Board

SEICAV President
Dr. Gustavo Hidalgo.

SEICAV Vice President
Dr. José Vivas Guijarro.

SEICAV Secretary
Dr. Alfonso Zambrano.

 SEICAV Pro-secretary
Dr. Wishton Moreira.

SEICAV Vocal
Dr. Ricardo Ortíz.

SEICAV Vocal
Dr. Erwin Téllez.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....